Moderna | MRNA - Operating Profit


Moderna reported $130M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Acadia Pharmaceuticals USD 71.72M 33.88M Sep/2026
Agios Pharmaceuticals USD -110.55M 527K Jun/2026
Alnylam Pharmaceuticals USD 179.66M 67.06M Sep/2026
Amgen USD 4.68B 65M Sep/2026
Arrowhead Research USD -170.09M 28.83M Jun/2026
Biogen USD 419.5M 663.3M Sep/2026
BioMarin Pharmaceutical USD 205.6M 100M Sep/2026
Celltrion KRW 19.31B 6.4B Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Dianthus Therapeutics USD -61.48M 14.95M Jun/2026
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Gilead Sciences USD 3.85B 1.17B Jun/2026
GlaxoSmithKline GBP 2.86B 251M Sep/2026
Incyte USD -707.47M 1.41B Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Moderna USD 130M 945M Sep/2026
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pharma Mar EUR 7.65M 9.06M Sep/2026
Puma Biotechnology USD 22.08M 24.26M Sep/2024
Qiagen NV USD 141.4M 24.77M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Sangamo BioSciences USD -33.51M 12.77M Jun/2024
Sarepta Therapeutics USD -9.04M 22.33M Sep/2026
Sartorius EUR 179.8M 15.8M Sep/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -110M 35M Sep/2026
United Therapeutics USD 241.3M 89.5M Sep/2026
Vertex Pharmaceuticals USD 1.26B 11.3M Sep/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 222.81M 140.02M Sep/2026